Literature DB >> 19660445

Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl as markers of large abdominal aortic aneurysms.

Carl Ekman1, Despina Flondell Site, Anders Gottsäter, Bengt Lindblad, Björn Dahlbäck.   

Abstract

OBJECTIVE: The tyrosine kinase receptor Axl is expressed in the vasculature and Gas6 is the ligand. The extracellular part of Axl (sAxl) can be found in circulation. The aim of this study was to determine plasma concentrations of Gas6 and sAxl in patients with abdominal aortic aneurysms (AAA) and to evaluate if Gas6 and sAxl can be used as biomarkers. DESIGN AND METHODS: Immunoassays for sAxl and Gas6 were used to investigate plasma from AAA patients. Patients with large (n=123) or small AAA (n=122) were compared with healthy controls (n=141).
RESULTS: Gas6 correlated positively and sAxl correlated negatively with AAA size. As a consequence, the calculated Gas6/sAxl ratios correlated even better to AAA size. Forty percent of all patients with a large AAA had higher Gas6/sAxl ratio than any in the control group. DISCUSSION: The Gas6/Axl system might be involved in AAA pathogenesis, and the Gas6/sAxl ratio may be useful as a biomarker. Copyright 2009 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19660445     DOI: 10.1016/j.clinbiochem.2009.07.025

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  12 in total

Review 1.  Axl-dependent signalling: a clinical update.

Authors:  Vyacheslav A Korshunov
Journal:  Clin Sci (Lond)       Date:  2012-04       Impact factor: 6.124

2.  Serum growth arrest-specific protein 6 levels are a reliable biomarker of disease activity in systemic lupus erythematosus.

Authors:  Hyoun-Ah Kim; Jin-Young Nam; Ja-Young Jeon; Jeong-Mi An; Ju-Yang Jung; Chang-Bum Bae; Chang-Hee Suh
Journal:  J Clin Immunol       Date:  2012-08-23       Impact factor: 8.317

Review 3.  Does Axl have potential as a therapeutic target in pancreatic cancer?

Authors:  Wenting Du; Rolf A Brekken
Journal:  Expert Opin Ther Targets       Date:  2018-10-03       Impact factor: 6.902

4.  Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma.

Authors:  Patrick Reichl; Meng Fang; Patrick Starlinger; Katharina Staufer; Rudolf Nenutil; Petr Muller; Kristina Greplova; Dalibor Valik; Steven Dooley; Christine Brostjan; Thomas Gruenberger; Jiayun Shen; Kwan Man; Michael Trauner; Jun Yu; Chun Fang Gao; Wolfgang Mikulits
Journal:  Int J Cancer       Date:  2015-01-13       Impact factor: 7.396

5.  Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus.

Authors:  Carl Ekman; Andreas Jönsen; Gunnar Sturfelt; Anders A Bengtsson; Björn Dahlbäck
Journal:  Rheumatology (Oxford)       Date:  2011-01-28       Impact factor: 7.580

6.  Identification of the soluble form of tyrosine kinase receptor Axl as a potential biomarker for intracranial aneurysm rupture.

Authors:  Jing Xu; Feiqiang Ma; Wei Yan; Sen Qiao; Shengquan Xu; Yi Li; Jianhong Luo; Jianmin Zhang; Jinghua Jin
Journal:  BMC Neurol       Date:  2015-03-05       Impact factor: 2.474

7.  Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities.

Authors:  Erin D Lew; Jennifer Oh; Patrick G Burrola; Irit Lax; Anna Zagórska; Paqui G Través; Joseph Schlessinger; Greg Lemke
Journal:  Elife       Date:  2014-09-29       Impact factor: 8.140

8.  Effect of Common Genetic Variants of Growth Arrest-Specific 6 Gene on Insulin Resistance, Obesity and Type 2 Diabetes in an Asian Population.

Authors:  Chang-Hsun Hsieh; Ren-Hua Chung; Wen-Jane Lee; Ming-Wei Lin; Lee-Ming Chuang; Thomas Quertermous; Themistocles Assimes; Yi-Jen Hung; Ya-Wen Yu
Journal:  PLoS One       Date:  2015-08-18       Impact factor: 3.240

9.  Plasma concentrations predict aortic expression of growth-arrest-specific protein 6 in patients undergoing coronary artery bypass grafting.

Authors:  Chien-Hsing Lee; Yi-Shing Shieh; Chien-Sung Tsai; Yi-Jen Hung; Yi-Ting Tsai; Chih-Yuan Lin
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

10.  Diversification of TAM receptor tyrosine kinase function.

Authors:  Anna Zagórska; Paqui G Través; Erin D Lew; Ian Dransfield; Greg Lemke
Journal:  Nat Immunol       Date:  2014-09-07       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.